BOSTON, MA
Allocation by class
Portfolio Concentration
Top 3 weight
27.0%
Top 10 weight
55.3%
Voting Authority Distribution
Total shares with voting rights: 65.84M
Full voting authority
65.84M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Cullinan Therapeutics, Inc.SOLE | 230031106 | 9.73M | SH | $177.21M 10.81% | 9.73M | 0.00 | 0.00 |
Aktis Oncology, Inc.SOLE | 01021M104 | 4.84M | SH | $155.86M 9.50% | 4.84M | 0.00 | 0.00 |
Liquidia CorporationSOLE | 53635D202 | 1.39M | SH | $110.52M 6.74% | 1.39M | 0.00 | 0.00 |
Revolution Medicines, Inc.SOLE | 76155X100 | 492.48K | SH | $92.23M 5.62% | 492.48K | 0.00 | 0.00 |
Corcept Therapeutics, Inc.SOLE | 218352102 | 771.03K | SH | $67.04M 4.09% | 771.03K | 0.00 | 0.00 |
Edgewise Therapeutics IncSOLE | 28036F105 | 1.62M | SH | $65.85M 4.02% | 1.62M | 0.00 | 0.00 |
Travere Therapeutics IncSOLE | 89422G107 | 1.12M | SH | $63.78M 3.89% | 1.12M | 0.00 | 0.00 |
DBV Technologies S ASOLE | 23306J309 | 3.67M | SH | $60.13M 3.67% | 3.67M | 0.00 | 0.00 |
Trevi Therapeutics IncSOLE | 89532M101 | 3.07M | SH | $57.32M 3.50% | 3.07M | 0.00 | 0.00 |
Alumis IncSOLE | 022307102 | 2.02M | SH | $56.82M 3.46% | 2.02M | 0.00 | 0.00 |
Uniqure NVSOLE | N90064101 | 1.23M | SH | $56.46M 3.44% | 1.23M | 0.00 | 0.00 |
Ultragenyx Pharmaceuticals, Inc.SOLE | 90400D108 | 1.42M | SH | $47.35M 2.89% | 1.42M | 0.00 | 0.00 |
Relay Therapeutics Inc.SOLE | 75943R102 | 2.42M | SH | $45.20M 2.76% | 2.42M | 0.00 | 0.00 |
Abivax SASOLE | 00370M103 | 336.35K | SH | $44.82M 2.73% | 336.35K | 0.00 | 0.00 |
Dyne Therapeutics, Inc.SOLE | 26818M108 | 1.92M | SH | $42.69M 2.60% | 1.92M | 0.00 | 0.00 |
Dianthus Therapeutics IncSOLE | 252828108 | 420K | SH | $40.94M 2.50% | 420K | 0.00 | 0.00 |
BIOAGE Labs IncSOLE | 09077V100 | 1.67M | SH | $40.87M 2.49% | 1.67M | 0.00 | 0.00 |
Urogen Pharma LtdSOLE | M96088105 | 933.41K | SH | $34.35M 2.09% | 933.41K | 0.00 | 0.00 |
MoonLake ImmunotherapeuticsSOLE | 61559X104 | 1.61M | SH | $31.29M 1.91% | 1.61M | 0.00 | 0.00 |
Palvella Therapeutics IncSOLE | 697947109 | 204.03K | SH | $31.18M 1.90% | 204.03K | 0.00 | 0.00 |
Taysha Gene Therapies, Inc.SOLE | 877619106 | 4.50M | SH | $30.64M 1.87% | 4.50M | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | 87164F105 | 1.33M | SH | $29.15M 1.78% | 1.33M | 0.00 | 0.00 |
Monte Rosa Therapeutics IncSOLE | 61225M102 | 1.16M | SH | $28.10M 1.71% | 1.16M | 0.00 | 0.00 |
Zura Bio Ltd.SOLE | G9TY5A101 | 4.47M | SH | $26.39M 1.61% | 4.47M | 0.00 | 0.00 |
Natera IncSOLE | 632307104 | 92.64K | SH | $25.15M 1.53% | 92.64K | 0.00 | 0.00 |